Global Avian Influenza Vaccines Market Insights and Forecast to 2028

Global Avian Influenza Vaccines Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Avian Influenza Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Avian Influenza Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 H5+H7 Avian Influenza Vaccines
1.2.3 H9 Avian Influenza Vaccines
1.3 Market by Application
1.3.1 Global Avian Influenza Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Chicken Avian Influenza Vaccines
1.3.3 Duck & Goose Avian Influenza Vaccines
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Avian Influenza Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Avian Influenza Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Avian Influenza Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Avian Influenza Vaccines Sales by Region
2.4.1 Global Avian Influenza Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Avian Influenza Vaccines by Region (2023-2028)
2.5 Global Avian Influenza Vaccines Revenue by Region
2.5.1 Global Avian Influenza Vaccines Revenue by Region (2017-2022)
2.5.2 Global Avian Influenza Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Avian Influenza Vaccines Sales by Manufacturers
3.1.1 Global Top Avian Influenza Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Avian Influenza Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Avian Influenza Vaccines in 2021
3.2 Global Avian Influenza Vaccines Revenue by Manufacturers
3.2.1 Global Avian Influenza Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Avian Influenza Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Avian Influenza Vaccines Revenue in 2021
3.3 Global Avian Influenza Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Avian Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Avian Influenza Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Avian Influenza Vaccines Sales by Type
4.1.1 Global Avian Influenza Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Avian Influenza Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Avian Influenza Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Avian Influenza Vaccines Revenue by Type
4.2.1 Global Avian Influenza Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Avian Influenza Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Avian Influenza Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Avian Influenza Vaccines Price by Type
4.3.1 Global Avian Influenza Vaccines Price by Type (2017-2022)
4.3.2 Global Avian Influenza Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Avian Influenza Vaccines Sales by Application
5.1.1 Global Avian Influenza Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Avian Influenza Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Avian Influenza Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Avian Influenza Vaccines Revenue by Application
5.2.1 Global Avian Influenza Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Avian Influenza Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Avian Influenza Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Avian Influenza Vaccines Price by Application
5.3.1 Global Avian Influenza Vaccines Price by Application (2017-2022)
5.3.2 Global Avian Influenza Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Avian Influenza Vaccines Market Size by Type
6.1.1 North America Avian Influenza Vaccines Sales by Type (2017-2028)
6.1.2 North America Avian Influenza Vaccines Revenue by Type (2017-2028)
6.2 North America Avian Influenza Vaccines Market Size by Application
6.2.1 North America Avian Influenza Vaccines Sales by Application (2017-2028)
6.2.2 North America Avian Influenza Vaccines Revenue by Application (2017-2028)
6.3 North America Avian Influenza Vaccines Market Size by Country
6.3.1 North America Avian Influenza Vaccines Sales by Country (2017-2028)
6.3.2 North America Avian Influenza Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Avian Influenza Vaccines Market Size by Type
7.1.1 Europe Avian Influenza Vaccines Sales by Type (2017-2028)
7.1.2 Europe Avian Influenza Vaccines Revenue by Type (2017-2028)
7.2 Europe Avian Influenza Vaccines Market Size by Application
7.2.1 Europe Avian Influenza Vaccines Sales by Application (2017-2028)
7.2.2 Europe Avian Influenza Vaccines Revenue by Application (2017-2028)
7.3 Europe Avian Influenza Vaccines Market Size by Country
7.3.1 Europe Avian Influenza Vaccines Sales by Country (2017-2028)
7.3.2 Europe Avian Influenza Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Avian Influenza Vaccines Market Size by Type
8.1.1 Asia Pacific Avian Influenza Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Avian Influenza Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Avian Influenza Vaccines Market Size by Application
8.2.1 Asia Pacific Avian Influenza Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Avian Influenza Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Avian Influenza Vaccines Market Size by Region
8.3.1 Asia Pacific Avian Influenza Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Avian Influenza Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Avian Influenza Vaccines Market Size by Type
9.1.1 Latin America Avian Influenza Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Avian Influenza Vaccines Revenue by Type (2017-2028)
9.2 Latin America Avian Influenza Vaccines Market Size by Application
9.2.1 Latin America Avian Influenza Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Avian Influenza Vaccines Revenue by Application (2017-2028)
9.3 Latin America Avian Influenza Vaccines Market Size by Country
9.3.1 Latin America Avian Influenza Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Avian Influenza Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Avian Influenza Vaccines Market Size by Type
10.1.1 Middle East and Africa Avian Influenza Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Avian Influenza Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Avian Influenza Vaccines Market Size by Application
10.2.1 Middle East and Africa Avian Influenza Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Avian Influenza Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Avian Influenza Vaccines Market Size by Country
10.3.1 Middle East and Africa Avian Influenza Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Avian Influenza Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merial
11.1.1 Merial Corporation Information
11.1.2 Merial Overview
11.1.3 Merial Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merial Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merial Recent Developments
11.2 QYH Biotech
11.2.1 QYH Biotech Corporation Information
11.2.2 QYH Biotech Overview
11.2.3 QYH Biotech Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 QYH Biotech Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 QYH Biotech Recent Developments
11.3 DHN
11.3.1 DHN Corporation Information
11.3.2 DHN Overview
11.3.3 DHN Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 DHN Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 DHN Recent Developments
11.4 HVRI
11.4.1 HVRI Corporation Information
11.4.2 HVRI Overview
11.4.3 HVRI Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 HVRI Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 HVRI Recent Developments
11.5 CEVA
11.5.1 CEVA Corporation Information
11.5.2 CEVA Overview
11.5.3 CEVA Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 CEVA Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CEVA Recent Developments
11.6 Elanco (Lohmann )
11.6.1 Elanco (Lohmann ) Corporation Information
11.6.2 Elanco (Lohmann ) Overview
11.6.3 Elanco (Lohmann ) Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Elanco (Lohmann ) Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Elanco (Lohmann ) Recent Developments
11.7 Yebio
11.7.1 Yebio Corporation Information
11.7.2 Yebio Overview
11.7.3 Yebio Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Yebio Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Yebio Recent Developments
11.8 Zoetis
11.8.1 Zoetis Corporation Information
11.8.2 Zoetis Overview
11.8.3 Zoetis Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Zoetis Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Zoetis Recent Developments
11.9 FATRO
11.9.1 FATRO Corporation Information
11.9.2 FATRO Overview
11.9.3 FATRO Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 FATRO Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 FATRO Recent Developments
11.10 Kyoto Biken
11.10.1 Kyoto Biken Corporation Information
11.10.2 Kyoto Biken Overview
11.10.3 Kyoto Biken Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Kyoto Biken Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Kyoto Biken Recent Developments
11.11 CAVAC
11.11.1 CAVAC Corporation Information
11.11.2 CAVAC Overview
11.11.3 CAVAC Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 CAVAC Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 CAVAC Recent Developments
11.12 Ringpu Biology
11.12.1 Ringpu Biology Corporation Information
11.12.2 Ringpu Biology Overview
11.12.3 Ringpu Biology Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Ringpu Biology Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Ringpu Biology Recent Developments
11.13 Vaksindo
11.13.1 Vaksindo Corporation Information
11.13.2 Vaksindo Overview
11.13.3 Vaksindo Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Vaksindo Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Vaksindo Recent Developments
11.14 ChengDu Tecbond
11.14.1 ChengDu Tecbond Corporation Information
11.14.2 ChengDu Tecbond Overview
11.14.3 ChengDu Tecbond Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 ChengDu Tecbond Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 ChengDu Tecbond Recent Developments
11.15 Sindh Poultry Vaccine Centre
11.15.1 Sindh Poultry Vaccine Centre Corporation Information
11.15.2 Sindh Poultry Vaccine Centre Overview
11.15.3 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Sindh Poultry Vaccine Centre Recent Developments
11.16 Merck Animal Health
11.16.1 Merck Animal Health Corporation Information
11.16.2 Merck Animal Health Overview
11.16.3 Merck Animal Health Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Merck Animal Health Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Merck Animal Health Recent Developments
11.17 Medion
11.17.1 Medion Corporation Information
11.17.2 Medion Overview
11.17.3 Medion Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Medion Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Medion Recent Developments
11.18 Avimex Animal Health
11.18.1 Avimex Animal Health Corporation Information
11.18.2 Avimex Animal Health Overview
11.18.3 Avimex Animal Health Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Avimex Animal Health Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Avimex Animal Health Recent Developments
11.19 JOVAC
11.19.1 JOVAC Corporation Information
11.19.2 JOVAC Overview
11.19.3 JOVAC Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 JOVAC Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 JOVAC Recent Developments
11.20 Bio-Labs
11.20.1 Bio-Labs Corporation Information
11.20.2 Bio-Labs Overview
11.20.3 Bio-Labs Avian Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Bio-Labs Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Bio-Labs Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Avian Influenza Vaccines Industry Chain Analysis
12.2 Avian Influenza Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Avian Influenza Vaccines Production Mode & Process
12.4 Avian Influenza Vaccines Sales and Marketing
12.4.1 Avian Influenza Vaccines Sales Channels
12.4.2 Avian Influenza Vaccines Distributors
12.5 Avian Influenza Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Avian Influenza Vaccines Industry Trends
13.2 Avian Influenza Vaccines Market Drivers
13.3 Avian Influenza Vaccines Market Challenges
13.4 Avian Influenza Vaccines Market Restraints
14 Key Findings in The Global Avian Influenza Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Avian Influenza Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of H5+H7 Avian Influenza Vaccines
Table 3. Major Manufacturers of H9 Avian Influenza Vaccines
Table 4. Global Avian Influenza Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Avian Influenza Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Avian Influenza Vaccines Sales by Region (2017-2022) & (M Doses)
Table 7. Global Avian Influenza Vaccines Sales Market Share by Region (2017-2022)
Table 8. Global Avian Influenza Vaccines Sales by Region (2023-2028) & (M Doses)
Table 9. Global Avian Influenza Vaccines Sales Market Share by Region (2023-2028)
Table 10. Global Avian Influenza Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Avian Influenza Vaccines Revenue Market Share by Region (2017-2022)
Table 12. Global Avian Influenza Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Avian Influenza Vaccines Revenue Market Share by Region (2023-2028)
Table 14. Global Avian Influenza Vaccines Sales by Manufacturers (2017-2022) & (M Doses)
Table 15. Global Avian Influenza Vaccines Sales Share by Manufacturers (2017-2022)
Table 16. Global Avian Influenza Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Avian Influenza Vaccines Revenue Share by Manufacturers (2017-2022)
Table 18. Avian Influenza Vaccines Price by Manufacturers (2017-2022) &(USD/K Doses)
Table 19. Global Avian Influenza Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Avian Influenza Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Avian Influenza Vaccines as of 2021)
Table 21. Avian Influenza Vaccines Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Avian Influenza Vaccines Product Offered
Table 23. Date of Manufacturers Enter into Avian Influenza Vaccines Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Avian Influenza Vaccines Sales by Type (2017-2022) & (M Doses)
Table 26. Global Avian Influenza Vaccines Sales by Type (2023-2028) & (M Doses)
Table 27. Global Avian Influenza Vaccines Sales Share by Type (2017-2022)
Table 28. Global Avian Influenza Vaccines Sales Share by Type (2023-2028)
Table 29. Global Avian Influenza Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Avian Influenza Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Avian Influenza Vaccines Revenue Share by Type (2017-2022)
Table 32. Global Avian Influenza Vaccines Revenue Share by Type (2023-2028)
Table 33. Avian Influenza Vaccines Price by Type (2017-2022) & (USD/K Doses)
Table 34. Global Avian Influenza Vaccines Price Forecast by Type (2023-2028) & (USD/K Doses)
Table 35. Global Avian Influenza Vaccines Sales by Application (2017-2022) & (M Doses)
Table 36. Global Avian Influenza Vaccines Sales by Application (2023-2028) & (M Doses)
Table 37. Global Avian Influenza Vaccines Sales Share by Application (2017-2022)
Table 38. Global Avian Influenza Vaccines Sales Share by Application (2023-2028)
Table 39. Global Avian Influenza Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Avian Influenza Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Avian Influenza Vaccines Revenue Share by Application (2017-2022)
Table 42. Global Avian Influenza Vaccines Revenue Share by Application (2023-2028)
Table 43. Avian Influenza Vaccines Price by Application (2017-2022) & (USD/K Doses)
Table 44. Global Avian Influenza Vaccines Price Forecast by Application (2023-2028) & (USD/K Doses)
Table 45. North America Avian Influenza Vaccines Sales by Type (2017-2022) & (M Doses)
Table 46. North America Avian Influenza Vaccines Sales by Type (2023-2028) & (M Doses)
Table 47. North America Avian Influenza Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Avian Influenza Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Avian Influenza Vaccines Sales by Application (2017-2022) & (M Doses)
Table 50. North America Avian Influenza Vaccines Sales by Application (2023-2028) & (M Doses)
Table 51. North America Avian Influenza Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Avian Influenza Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Avian Influenza Vaccines Sales by Country (2017-2022) & (M Doses)
Table 54. North America Avian Influenza Vaccines Sales by Country (2023-2028) & (M Doses)
Table 55. North America Avian Influenza Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Avian Influenza Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Avian Influenza Vaccines Sales by Type (2017-2022) & (M Doses)
Table 58. Europe Avian Influenza Vaccines Sales by Type (2023-2028) & (M Doses)
Table 59. Europe Avian Influenza Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Avian Influenza Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Avian Influenza Vaccines Sales by Application (2017-2022) & (M Doses)
Table 62. Europe Avian Influenza Vaccines Sales by Application (2023-2028) & (M Doses)
Table 63. Europe Avian Influenza Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Avian Influenza Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Avian Influenza Vaccines Sales by Country (2017-2022) & (M Doses)
Table 66. Europe Avian Influenza Vaccines Sales by Country (2023-2028) & (M Doses)
Table 67. Europe Avian Influenza Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Avian Influenza Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Avian Influenza Vaccines Sales by Type (2017-2022) & (M Doses)
Table 70. Asia Pacific Avian Influenza Vaccines Sales by Type (2023-2028) & (M Doses)
Table 71. Asia Pacific Avian Influenza Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Avian Influenza Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Avian Influenza Vaccines Sales by Application (2017-2022) & (M Doses)
Table 74. Asia Pacific Avian Influenza Vaccines Sales by Application (2023-2028) & (M Doses)
Table 75. Asia Pacific Avian Influenza Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Avian Influenza Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Avian Influenza Vaccines Sales by Region (2017-2022) & (M Doses)
Table 78. Asia Pacific Avian Influenza Vaccines Sales by Region (2023-2028) & (M Doses)
Table 79. Asia Pacific Avian Influenza Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Avian Influenza Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Avian Influenza Vaccines Sales by Type (2017-2022) & (M Doses)
Table 82. Latin America Avian Influenza Vaccines Sales by Type (2023-2028) & (M Doses)
Table 83. Latin America Avian Influenza Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Avian Influenza Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Avian Influenza Vaccines Sales by Application (2017-2022) & (M Doses)
Table 86. Latin America Avian Influenza Vaccines Sales by Application (2023-2028) & (M Doses)
Table 87. Latin America Avian Influenza Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Avian Influenza Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Avian Influenza Vaccines Sales by Country (2017-2022) & (M Doses)
Table 90. Latin America Avian Influenza Vaccines Sales by Country (2023-2028) & (M Doses)
Table 91. Latin America Avian Influenza Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Avian Influenza Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Avian Influenza Vaccines Sales by Type (2017-2022) & (M Doses)
Table 94. Middle East and Africa Avian Influenza Vaccines Sales by Type (2023-2028) & (M Doses)
Table 95. Middle East and Africa Avian Influenza Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Avian Influenza Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Avian Influenza Vaccines Sales by Application (2017-2022) & (M Doses)
Table 98. Middle East and Africa Avian Influenza Vaccines Sales by Application (2023-2028) & (M Doses)
Table 99. Middle East and Africa Avian Influenza Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Avian Influenza Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Avian Influenza Vaccines Sales by Country (2017-2022) & (M Doses)
Table 102. Middle East and Africa Avian Influenza Vaccines Sales by Country (2023-2028) & (M Doses)
Table 103. Middle East and Africa Avian Influenza Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Avian Influenza Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 105. Merial Corporation Information
Table 106. Merial Description and Major Businesses
Table 107. Merial Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 108. Merial Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Merial Recent Developments
Table 110. QYH Biotech Corporation Information
Table 111. QYH Biotech Description and Major Businesses
Table 112. QYH Biotech Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 113. QYH Biotech Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. QYH Biotech Recent Developments
Table 115. DHN Corporation Information
Table 116. DHN Description and Major Businesses
Table 117. DHN Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 118. DHN Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. DHN Recent Developments
Table 120. HVRI Corporation Information
Table 121. HVRI Description and Major Businesses
Table 122. HVRI Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 123. HVRI Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. HVRI Recent Developments
Table 125. CEVA Corporation Information
Table 126. CEVA Description and Major Businesses
Table 127. CEVA Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 128. CEVA Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. CEVA Recent Developments
Table 130. Elanco (Lohmann ) Corporation Information
Table 131. Elanco (Lohmann ) Description and Major Businesses
Table 132. Elanco (Lohmann ) Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 133. Elanco (Lohmann ) Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Elanco (Lohmann ) Recent Developments
Table 135. Yebio Corporation Information
Table 136. Yebio Description and Major Businesses
Table 137. Yebio Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 138. Yebio Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Yebio Recent Developments
Table 140. Zoetis Corporation Information
Table 141. Zoetis Description and Major Businesses
Table 142. Zoetis Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 143. Zoetis Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Zoetis Recent Developments
Table 145. FATRO Corporation Information
Table 146. FATRO Description and Major Businesses
Table 147. FATRO Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 148. FATRO Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. FATRO Recent Developments
Table 150. Kyoto Biken Corporation Information
Table 151. Kyoto Biken Description and Major Businesses
Table 152. Kyoto Biken Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 153. Kyoto Biken Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Kyoto Biken Recent Developments
Table 155. CAVAC Corporation Information
Table 156. CAVAC Description and Major Businesses
Table 157. CAVAC Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 158. CAVAC Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. CAVAC Recent Developments
Table 160. Ringpu Biology Corporation Information
Table 161. Ringpu Biology Description and Major Businesses
Table 162. Ringpu Biology Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 163. Ringpu Biology Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Ringpu Biology Recent Developments
Table 165. Vaksindo Corporation Information
Table 166. Vaksindo Description and Major Businesses
Table 167. Vaksindo Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 168. Vaksindo Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Vaksindo Recent Developments
Table 170. ChengDu Tecbond Corporation Information
Table 171. ChengDu Tecbond Description and Major Businesses
Table 172. ChengDu Tecbond Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 173. ChengDu Tecbond Avian Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. ChengDu Tecbond Recent Developments
Table 1

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Encephalitis Vaccination Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102

According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......

Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......

Global Avian Influenza Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155

According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......

Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......

Global Influenza Vaccine Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......

Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117

Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......

Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......

2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel

Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107

This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs